Assessing the Value of BMI and Aerobic Capacity as Surrogate Markers for the Severity of Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Who Are Obese.

MLA

Smith, Cassandra, et al. “Assessing the Value of BMI and Aerobic Capacity as Surrogate Markers for the Severity of Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Who Are Obese.” Clinical Medicine Insights. Cardiology, vol. 10, May 2016, pp. 61–65. EBSCOhost, https://doi.org/10.4137/CMC.S38116.

APA

Smith, C., Asrar Ul Haq, M., Jerums, G., Hanson, E., Hayes, A., Allen, J. D., Sbaraglia, M., Selig, S., Wong, C., Hare, D. L., & Levinger, I. (2016). Assessing the Value of BMI and Aerobic Capacity as Surrogate Markers for the Severity of Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Who Are Obese. Clinical Medicine Insights. Cardiology, 10, 61–65. https://doi.org/10.4137/CMC.S38116

Chicago

Smith, Cassandra, Muhammad Asrar Ul Haq, George Jerums, Erik Hanson, Alan Hayes, Jason D Allen, Melissa Sbaraglia, et al. 2016. “Assessing the Value of BMI and Aerobic Capacity as Surrogate Markers for the Severity of Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Who Are Obese.” Clinical Medicine Insights. Cardiology 10 (May): 61–65. doi:10.4137/CMC.S38116.